Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025

Description

Generative AI in drug discovery utilizes advanced machine learning techniques, particularly generative models, to create and identify new pharmaceutical compounds. These AI systems analyze vast datasets encompassing chemical properties, biological activity, and existing drug information to predict and generate novel molecules with potential therapeutic benefits. The primary goal is to expedite the discovery of novel pharmaceutical compounds with therapeutic potential, streamlining the drug development process by leveraging extensive data to efficiently predict and generate new molecules.

The main types of generative artificial intelligence (AI) in drug discovery are small molecule and large molecule. Small molecules are chemically synthesized drugs with typically low molecular weights. Various technologies including deep learning, machine learning, reinforcement learning, molecular docking, and quantum computing are employed by a range of end-users, including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations (CROs), and others.

The generative artificial intelligence (AI) in drug discovery market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in drug discovery market statistics, including generative artificial intelligence (AI) in drug discovery industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in drug discovery market share, detailed generative artificial intelligence (AI) in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in drug discovery industry. This generative artificial intelligence (AI) in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative artificial intelligence (AI) in drug discovery market size has grown exponentially in recent years. It will grow from $0.19 billion in 2024 to $0.25 billion in 2025 at a compound annual growth rate (CAGR) of 30.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, development of new drug discoveries and clinical trials, supporting AI integration into healthcare and drug development, growing biotech industries and increasing governmental support.

The generative artificial intelligence (AI) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $0.74 billion in 2029 at a compound annual growth rate (CAGR) of 30.6%. The growth in the forecast period can be attributed to demand for cost-effective drug discovery drives adoption of generative AI, growing collaborations among market players, increasing computational power, integration of generative AI with other emerging technologies and rapid drug development. Major trends in the forecast period include advanced technologies, integration of generative AI with experimental biology, high-throughput screening for accelerated drug discovery pipelines, development of AI-driven platforms for drug repurposing and rising adoption of cloud-based AI solutions for collaborative drug discovery efforts.

The growing number of clinical trials is expected to drive the expansion of generative AI in the drug discovery market. Clinical trials involve testing new medical treatments or procedures on human volunteers to assess their safety and effectiveness, with the goal of collecting scientific data on their suitability for human use. The increase in clinical trials can be attributed to several factors, including advancements in medical research, a rising disease burden, regulatory changes, the globalization of clinical research, greater patient advocacy and awareness, industry competition, technological innovations, and increased funding. Data from clinical trials enhances generative AI models, which accelerate drug discovery by predicting interactions and designing compounds. This collaboration enables personalized medicine, optimizes treatment effectiveness, enhances patient outcomes, and transforms the pharmaceutical industry. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the annual number of clinical trials launched in the UK rose by 4.3%, from 394 trials in 2021 to 411 in 2022. Therefore, the increasing number of clinical trials is driving the growth of generative AI in the drug discovery market.

Key players in the generative AI drug discovery market are developing sophisticated AI-powered tools to expedite drug development processes. These tools leverage AI and machine learning to streamline drug discovery, design, and clinical trials through predictive analytics. They enhance efficiency in target identification, compound screening, preclinical development, regulatory compliance, and manufacturing. For instance, in May 2023, Google Cloud introduced two groundbreaking AI-driven solutions, the Target and Lead Identification Suite and the Multiomics Suite. These solutions empower biotech, pharmaceutical, and public sector organizations by improving drug discovery and precision medicine. The Target and Lead Identification Suite aids researchers in understanding amino acid functions and predicting protein structures, while the Multiomics Suite accelerates genomic data analysis, facilitating the development of personalized treatments.

In May 2023, Recursion Pharmaceuticals acquired Cyclica and Valence for $40 million and $47.5 million, respectively, bolstering its drug discovery capabilities through advanced technologies. These acquisitions position Recursion as a prominent hub for top-tier professionals in machine learning and AI, poised to innovate and shape the future of drug discovery. Cyclica Inc., based in Canada, specializes in data-driven drug discovery and artificial intelligence. Valence Labs, also based in Canada, focuses on advancing AI in drug discovery.

Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrodinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc

North America was the largest region in the generative AI in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative artificial intelligence (AI) in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative AI in drug discovery market includes revenues earned by entities by providing services such as molecule generation, optimization, virtual screening, predictive modeling, de novo drug design, and consulting support. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative AI in drug discovery market also includes sales of quantum computers, high-performance computing (HPC) clusters, tensor processing units, graphics processing units, and preclinical development tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative artificial intelligence (ai) in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative artificial intelligence (ai) in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative artificial intelligence (ai) in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Small Molecule; Large Molecule
2) By Technology: Deep Learning; Machine Learning; Reinforcement Learning; Molecular Docking; Quantum Computing
3) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutions; Contract Research Organizations (CROs); Other End-Users
Subsegments:
1) By Small Molecule: Drug Design And Optimization; Lead Discovery And Identification; Toxicology Prediction; Molecular Property Prediction; ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction
2) By Large Molecule: Protein Structure Prediction; Antibody Design; Biologics Optimization; Peptide Design; Biopharmaceutical Discovery And Optimization
Companies Mentioned: Bayer AG; NVIDIA Corporation; Merck KGaA; IBM Research; Schrodinger Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30308

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Drug Discovery Market Characteristics

3. Generative Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Generative Artificial Intelligence (AI) In Drug Discovery Growth Analysis And Strategic Analysis Framework

5.1. Global Generative Artificial Intelligence (AI) In Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Growth Rate Analysis
5.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Generative Artificial Intelligence (AI) In Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Generative Artificial Intelligence (AI) In Drug Discovery Total Addressable Market (TAM)

6. Generative Artificial Intelligence (AI) In Drug Discovery Market Segmentation

6.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Molecule
Large Molecule
6.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deep Learning
Machine Learning
Reinforcement Learning
Molecular Docking
Quantum Computing
6.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institutions
Contract Research Organizations (CROs)
Other End-Users
6.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Design and Optimization
Lead Discovery and Identification
Toxicology Prediction
Molecular Property Prediction
ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Prediction
6.5. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Structure Prediction
Antibody Design
Biologics Optimization
Peptide Design
Biopharmaceutical Discovery and Optimization

7. Generative Artificial Intelligence (AI) In Drug Discovery Market Regional And Country Analysis

7.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market

8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative Artificial Intelligence (AI) In Drug Discovery Market

9.1. China Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
9.2. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative Artificial Intelligence (AI) In Drug Discovery Market

10.1. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market

11.1. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
11.2. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market

12.1. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market

13.1. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market

14.1. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
14.2. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

15.1. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
15.2. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Drug Discovery Market

16.1. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market

17.1. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative Artificial Intelligence (AI) In Drug Discovery Market

18.1. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market

19.1. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market

20.1. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

21.1. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
21.2. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market

22.1. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Drug Discovery Market

23.1. North America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
23.2. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Drug Discovery Market

24.1. USA Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
24.2. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market

25.1. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
25.2. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Drug Discovery Market

26.1. South America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
26.2. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market

27.1. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market

28.1. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
28.2. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market

29.1. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
29.2. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Company Profiles

30.1. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape
30.2. Generative Artificial Intelligence (AI) In Drug Discovery Market Company Profiles
- 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. IBM Research Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Generative Artificial Intelligence (AI) In Drug Discovery Market Other Major And Innovative Companies

31.1. Valo Health
31.2. BenevolentAI
31.3. XtalPi Inc.
31.4. Insilico Medicine Inc.
31.5. Recursion Pharmaceuticals Inc.
31.6. Exscientia
31.7. Atomwise Inc.
31.8. InveniAI LLC
31.9. Healx
31.10. Aitia
31.11. Cloud Pharmaceuticals Inc.
31.12. Optibrium
31.13. Aiforia
31.14. BioSymetrics Inc.
31.15. Collaborations Pharmaceuticals Inc.

32. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Drug Discovery Market

34. Recent Developments In The Generative Artificial Intelligence (AI) In Drug Discovery Market

35. Generative Artificial Intelligence (AI) In Drug Discovery Market High Potential Countries, Segments and Strategies

35.1 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
35.2 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
35.3 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer